Skip to content

Author

L. Pal

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Fc‐Dependent Targeting of the GAS6–MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21

ABSTRACT Resistance of lung cancer to EGFR‐targeting tyrosine kinase inhibitors (TKIs) like osimertinib frequently results from secondary mutations or activation of bypass signaling pathways. Re‐analysis of clinical data unveiled elevated expression of GAS6 and its receptor MERTK in lung cancer patients developing resi...

Suvendu Giri, Boobash-Raj Selvadurai, Nitin Gupta et al. · 0 citations
Open access Sep 2026

A Machine Learning Framework Enables Supervised Treatment Response Prediction from Tumor Transcriptomics across Cancer Types.

Robustness analysis revealed that predictive performance plateaued for some therapies with increasing training cohorts but continued to improve for others, suggesting inherent limits of supervised brute-force learning for certain treatments, but additional data and deeper mechanistic modeling may further enhance transc...

L. Pal, E. Gertz, N. Nair et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.